Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Gross Margin: 2012-2024

Historic Gross Margin for Ani Pharmaceuticals (ANIP) over the last 13 years, with Dec 2024 value amounting to 59.27%.

  • Ani Pharmaceuticals' Gross Margin rose 153.00% to 59.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.14%, marking a year-over-year increase of 135.00%. This contributed to the annual value of 59.27% for FY2024, which is 344.00% down from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' Gross Margin is 59.27%, which was down 5.49% from 62.71% recorded in FY2023.
  • Ani Pharmaceuticals' 5-year Gross Margin high stood at 62.71% for FY2023, and its period low was 53.45% during FY2021.
  • In the last 3 years, Ani Pharmaceuticals' Gross Margin had a median value of 59.27% in 2024 and averaged 59.37%.
  • Per our database at Business Quant, Ani Pharmaceuticals' Gross Margin crashed by 1,123bps in 2020 and then surged by 658bps in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Gross Margin (Yearly) stood at 58.19% in 2020, then tumbled by 474bps to 53.45% in 2021, then surged by 268bps to 56.13% in 2022, then spiked by 658bps to 62.71% in 2023, then crashed by 344bps to 59.27% in 2024.